PFE
Pfizer·NYSE
--
--(--)
--
--(--)
PFE fundamentals
Pfizer (PFE) Revenue Breakdown: Q4 2025 Business & Regional Performance
Pfizer (PFE) reported total revenue of 17.56B USD in Q4 2025, with its core business segment Biopharmaceutical Products contributing 97.65%. Regionally, International remained the largest market, accounting for 48.06% of total revenue. Explore Pfizer's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Pfizer (PFE) reported total revenue of 17.56B USD in Q4 2025, with its core business segment Biopharmaceutical Products contributing 97.65%. Regionally, International remained the largest market, accounting for 48.06% of total revenue. Explore Pfizer's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is the revenue and EPS growth rate for Pfizer year over year?What factors drove the changes in Pfizer's revenue and profit?Did Pfizer beat or miss consensus estimates last quarter?What is Pfizer's latest dividend and current dividend yield?What is the market's earnings forecast for Pfizer next quarter?What is Pfizer's gross profit margin?What guidance did Pfizer's management provide for the next earnings period?What were the key takeaways from Pfizer’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
